{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T11:53:58Z","timestamp":1775908438098,"version":"3.50.1"},"reference-count":48,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Becker muscular dystrophy (BMD) is an X-linked recessive disorder caused by dystrophin gene mutations. The phenotype and evolution of this muscle disorder are extremely clinical variable. In the last years, circulating biomarkers have acquired remarkable importance in their use as noninvasive biological indicators of prognosis and in monitoring muscle disease progression, especially when associated to muscle MRI imaging. We investigated the levels of circulating microRNAs (myo-miRNAs and inflammatory miRNAs) and of the proteins follistatin (FSTN) and myostatin (GDF-8) and compared results with clinical and radiological imaging data. In eight BMD patients, including two cases with evolving lower extremity weakness treated with deflazacort, we evaluated the expression level of 4 myo-miRNAs (miR-1, miR-206, miR-133a, and miR-133b), 3 inflammatory miRNAs (miR-146b, miR-155, and miR-221), FSTN, and GDF-8 proteins. In the two treated cases, there was pronounced posterior thigh and leg fibrofatty replacement assessed by muscle MRI by Mercuri score. The muscle-specific miR-206 was increased in all patients, and inflammatory miR-221 and miR-146b were variably elevated. A significant difference in myostatin expression was observed between steroid-treated and untreated patients. This study suggests that microRNAs and myostatin protein levels could be used to better understand the progression and management of the disease.<\/jats:p>","DOI":"10.3390\/diagnostics10090713","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T07:27:33Z","timestamp":1600414053000},"page":"713","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["MiRNAs, Myostatin, and Muscle MRI Imaging as Biomarkers of Clinical Features in Becker Muscular Dystrophy"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-3456","authenticated-orcid":false,"given":"Roberta","family":"Marozzo","sequence":"first","affiliation":[{"name":"IRCCS San Camillo Hospital, 30126 Venice, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7396-3022","authenticated-orcid":false,"given":"Valentina","family":"Pegoraro","sequence":"additional","affiliation":[{"name":"IRCCS San Camillo Hospital, 30126 Venice, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9554-8794","authenticated-orcid":false,"given":"Corrado","family":"Angelini","sequence":"additional","affiliation":[{"name":"IRCCS San Camillo Hospital, 30126 Venice, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/peds.2014-2044","article-title":"HHS public access","volume":"135","author":"Romitti","year":"2016","journal-title":"Pediatrics"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00007.2015","article-title":"Absence of dystrophin disrupts skeletal muscle signaling: Roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy","volume":"96","author":"Allen","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_5","first-page":"172","article-title":"Current and emerging therapies in Becker muscular dystrophy (BMD)","volume":"38","author":"Angelini","year":"2019","journal-title":"Acta Myol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16060","DOI":"10.1038\/s41598-017-16170-2","article-title":"Muscle MRI and functional outcome measures in Becker muscular dystrophy","volume":"7","author":"Barp","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/CON.0000000000000791","article-title":"The dystrophinopathies","volume":"25","author":"Thangarajh","year":"2019","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0022-510X(96)00144-X","article-title":"Prognostic factors in mild dystrophinopathies","volume":"142","author":"Angelini","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/BST20190282","article-title":"From diagnosis to therapy in Duchenne muscular dystrophy","volume":"48","author":"Babbs","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Haque, A., Cox, M., Sandler, R.D., and Hughes, M. (2020). A systematic review of internet-based information on dermatomyositis and polymyositis. Int. J. Rheum. Dis., 1\u20136.","DOI":"10.1111\/1756-185X.13929"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.mric.2019.04.009","article-title":"Comprehensive assessment of cardiac involvement in muscular dystrophies by cardiac MR imaging","volume":"27","author":"Rochitte","year":"2019","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s00415-011-5930-3","article-title":"Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I","volume":"258","author":"Palmieri","year":"2011","journal-title":"J. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/21678707.2019.1622412","article-title":"The clinical and molecular spectrum of autosomal dominant limb-girdle muscular dystrophies focusing on transportinopathy","volume":"7","author":"Angelini","year":"2019","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1212\/WNL.0000000000003217","article-title":"Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy","volume":"87","author":"Griggs","year":"2016","journal-title":"Neurology"},{"key":"ref_16","first-page":"1","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/med.20215","article-title":"Circulating MicroRNAs: A novel class of biomarkers to diagnose and monitor human cancers","volume":"32","author":"Zen","year":"2010","journal-title":"Med. Res. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12199-014-0405-7","article-title":"Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy","volume":"19","author":"Matsuzaka","year":"2014","journal-title":"Environ. Health Prev. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S2352-3026(19)30248-0","article-title":"Proliferation and differentiation","volume":"7","author":"Haematology","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7150\/ijbs.10921","article-title":"MiR-206, a key modulator of skeletal muscle development and disease","volume":"11","author":"Ma","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201100133","article-title":"MiRNAs as serum biomarkers for Duchenne muscular dystrophy","volume":"3","author":"Cacchiarelli","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1073\/pnas.0708115104","article-title":"Distinctive patterns of microRNA expression in primary muscular disorders","volume":"104","author":"Eisenberg","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lee, S.-J. (2007). Quadrupling muscle mass in mice by targeting TGF-\u00df signaling pathways. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000789"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mus.26761","article-title":"MiRNAs as biomarkers of phenotype in neutral lipid storage disease with myopathy","volume":"61","author":"Pegoraro","year":"2019","journal-title":"Muscle Nerve"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5414\/NP300889","article-title":"Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS","volume":"35","author":"Tasca","year":"2016","journal-title":"Clin. Neuropathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/ejpn.2002.0617","article-title":"A short protocol for muscle MRI in children with muscular dystrophies","volume":"6","author":"Mercuri","year":"2002","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zaharieva, I.T., Calissano, M., Scoto, M., Preston, M.D., Cirak, S., Feng, L., Collins, J., Kole, R., Guglieri, M., and Straub, V. (2013). Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular dystrophy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080263"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1038\/mtna.2012.26","article-title":"Expression analysis in multiple muscle groups and serum reveals complexity in the MicroRNA transcriptome of the mdx mouse with implications for therapy","volume":"1","author":"Roberts","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hrach, H.C., and Mangone, M. (2019). MiRNA profiling for early detection and treatment of Duchenne muscular dystrophy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184638"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/jnc.12662","article-title":"Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy","volume":"129","author":"Hu","year":"2014","journal-title":"J. Neurochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2020.00304","article-title":"Longitudinal study of three microRNAs in Duchenne muscular dystrophy and Becker muscular dystrophy","volume":"11","author":"Trifunov","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/jir.2018.0155","article-title":"MicroRNA-155: A master regulator of inflammation","volume":"39","author":"Mahesh","year":"2019","journal-title":"J. Interf. Cytokine Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2261","DOI":"10.1038\/cddis.2016.165","article-title":"MicroRNA-155 facilitates skeletal muscle regeneration by balancing pro- and anti-inflammatory macrophages","volume":"7","author":"Nie","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.freeradbiomed.2012.01.031","article-title":"Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: A novel anti-inflammation mechanism","volume":"52","author":"Zheng","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/23744235.2019.1671987","article-title":"MiR-146b protects against the inflammation injury in pediatric pneumonia through MyD88\/NF-\u03baB signaling pathway","volume":"52","author":"Zhang","year":"2019","journal-title":"Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"ra11","DOI":"10.1126\/scisignal.2004497","article-title":"STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-B to IL-6 signaling axis and STAT3-driven cancer phenotypes","volume":"7","author":"Xiang","year":"2014","journal-title":"Sci. Signal."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fimmu.2019.03087","article-title":"MiR-221-3p drives the shift of M2-macrophages to a pro-inflammatory function by suppressing JAK3\/STAT3 activation","volume":"10","author":"Quero","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.celrep.2015.07.066","article-title":"TNF-\u03b1-induced microRNAs control dystrophin expression in Becker muscular dystrophy","volume":"12","author":"Fiorillo","year":"2015","journal-title":"Cell Rep."},{"key":"ref_40","first-page":"17","article-title":"Limb-girdle muscular dystrophies type 2a and 2B: Clinical and radiological aspects","volume":"16","author":"Borsato","year":"2006","journal-title":"Basic Appl. Myol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.nmd.2016.09.002","article-title":"Muscle MRI in Duchenne muscular dystrophy: Evidence of a distinctive pattern","volume":"26","author":"Polavarapu","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00415-016-8379-6","article-title":"Reduced serum myostatin concentrations associated with genetic muscle disease progression","volume":"264","author":"Burch","year":"2017","journal-title":"J. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1038\/s41598-018-20524-9","article-title":"Blocking extracellular activation of myostatin as a strategy for treating muscle wasting","volume":"8","author":"Pirruccello","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41467-017-01486-4","article-title":"Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches","volume":"8","author":"Mariot","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JND-150083","article-title":"Follistatin gene therapy improves ambulation in Becker muscular dystrophy","volume":"2","author":"Sahenk","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/mt.2014.200","article-title":"A phase 1\/2a follistatin gene therapy trial for Becker muscular dystrophy","volume":"23","author":"Mendell","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exger.2018.03.019","article-title":"Limb muscle quality and quantity in elderly adults with dynapenia but not sarcopenia: An ultrasound imaging study","volume":"108","author":"Chang","year":"2018","journal-title":"Exp. Gerontol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2147\/DMSO.S219649","article-title":"Association between metabolic syndrome and limb muscle quantity and quality in older adults: A pilot ultrasound study","volume":"12","author":"Chang","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/9\/713\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:11:09Z","timestamp":1760177469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/9\/713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["diagnostics10090713"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics10090713","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]}}}